Pluri Inc.
PLURNASDAQHealthcare● Active
$2.31
$-0.05(-2.12%)
Market Cap$20770748
P/E Ratio—
52W High$5.96
52W Low$2.22
Pluri Inc.（PLUR）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · PLUR · 截至 Jun 9, 2026
关键指标
探索 Pluri Inc. 数据
plur stock data · financials财务快照
完整财报FY 2025Revenue$1.3M▲ +309.82% YoY
202320242025
pluri inc. revenue · plur revenue 2025FY 2025Net Income-$22.6M▼ 8.11% YoY
202320242025
pluri inc. net income · plur profit 2025FY 2025EPS$-3.56▲ +10.78% YoY
202320242025
plur eps · pluri inc. earnings per share 2025竞争对手与同行
plur competitors#TickerCompanyPriceChangeMkt Cap
#1PLURPluri Inc.
$2.31-2.12%$20.8M#2
ANTXAN2 Therapeutics, Inc.
$3.85+0.79%$105.5M#3
BOLDBoundless Bio, Inc.
$1.43+0.70%$32.1M#4
IBIOiBio, Inc.
$1.73-4.95%$27.3M#5
INTSIntensity Therapeutics, Inc.
$3.78+0.27%$7.1M#6
ITRMIterum Therapeutics plc
$0.03-10.98%$1.6M股票表现
完整历史1D-2.12%
1W-1.70%
1M-33.81%
3M-31.45%
YTD-22.74%
1Y-47.38%
5Y-93.32%
关于 Pluri Inc.
Pluri Inc. a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range …
what is pluri inc. · plur stock overview · pluri inc. company profile · who is pluri inc. ceo · plur NASDAQ · pluri inc. headquarters · pluri inc. business segments
关于股票概览与关键数据
Pluri Inc.（PLUR）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 30, 2003 在 NASDAQ 上市。截至最近交易日，PLUR 股价为 $2.31，市值约为 $20.8M。过去12个月累计回报 -47.38%，年初至今回报 -22.74%。
2025 财年 Pluri Inc. 营收 $1.3M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Pluri Inc.（PLUR）股价为 $2.31，在 NASDAQ 上市，52周区间为 $2.22 – $5.96。
PLUR 最新股价PLUR quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议